middle.news
Neuren gains potential trofinetide protection through 2041
10:34am on Tuesday 29th of September, 2026 AEST
•
Biotechnology
Read Story
Neuren gains potential trofinetide protection through 2041
10:34am on Tuesday 29th of September, 2026 AEST
Key Points
US Notice of Allowance for weight-banded trofinetide dosing
Expected protection through 28 March 2041
Almost five-year extension to existing US protection
Patent still requires standard administrative steps
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neuren Pharmaceuticals (ASX:NEU)
OPEN ARTICLE